Companies & Industry »Company News»Company News Details
Company News Details

BSE   22 Aug 14 | 12:00 AM

1225.60 3.5 (0.29%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   22 Aug 14 | 12:00 AM

1227.55 2.45 (0.2%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 1,111.40 (10.28%)
1 Month : Rs 1,087.95 (12.65%)
1 Year : Rs 662.95 (84.87%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
Hindalco Inds.182.052.36
St Bk of India2,523.602.26
HDFC Bank846.601.80
Infosys3,601.251.65
TCS2,461.651.22

Online Portfolio

You can create Online Portfolio here using the below button.